Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News EACTS 2024

TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb

Yael L. Maxwell

October 21, 2024

News Conference News EACTS 2024

AI-Based CT Can Accurately Screen Patients for TMVR

Yael L. Maxwell

October 15, 2024

Presentation EACTS 2024

Streamlining Transcatheter Mitral Valve Replacement Screening

Presenter: Martin Beyer

October 10, 2024

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

News Conference News NY Valves 2024

TEER May Be Option for Primary MR and ‘Red Zone’ Anatomy

Todd Neale

June 11, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Conference News STS 2024

SAVR After Failed TAVI on the Rise, With High Mortality

Yael L. Maxwell

February 05, 2024

Presentation Miami Valves 2024

Catheter Based Treatment of Structural Heart Disease: Year in Review

Presenter: Eduardo de Marchena

February 01, 2024

Advertisement

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb

AI-Based CT Can Accurately Screen Patients for TMVR

Streamlining Transcatheter Mitral Valve Replacement Screening

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

TCTMD’s Top 10 Most Popular Stories for August 2024

Valvular Heart Disease Has a Diversity Problem

TEER May Be Option for Primary MR and ‘Red Zone’ Anatomy

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Evoque and Patisiran: A Tale of Two Regulatory Journeys

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

SAVR After Failed TAVI on the Rise, With High Mortality

Catheter Based Treatment of Structural Heart Disease: Year in Review

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content